Retirement village operator Ryman Healthcare has been leading the NZX board thus far in July, with its share price up 14% – stronger than expected. Milford Investment Analyst Jeremy Hutton talks to Ryan Bridge about the reasons for optimism following a tough time for the company, which saw its share fall 80% over the past four years.